Health
Cardioprotective therapies fail to prevent LVEF decline in early breast cancer treatment – Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor long-term decline in left ventricular ejection fraction, a speaker reported.
According to data presented at the virtual American College of Cardiology Scientific Session, concomitant…
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoIs Auckland New Zealand’s New Cultural Capital?
-
General22 hours agoThree maps that show the scale of the NSW flood disaster
-
General12 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire